C Oreja-Guevara

Summary

Publications

  1. ncbi request reprint [Clinical pathways for the care of multiple sclerosis patients]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid, Espana
    Neurologia 25:156-62. 2010
  2. ncbi request reprint [Optic neuritis, multiple sclerosis-related or not: structural and functional study]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid, Espana
    Neurologia 25:78-82. 2010
  3. ncbi request reprint [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]
    J J Merino
    Instituto de Investigacion Sanitaria IdiPaz Hospital Universitario de La Paz HULP, Madrid, Espana
    Rev Neurol 52:101-11. 2011
  4. doi request reprint Spasticity in multiple sclerosis: results of a patient survey
    C Oreja-Guevara
    Multiple Sclerosis Unit, Department of Neurology, IdISSC, University Hospital San Carlos, Madrid, Spain
    Int J Neurosci 123:400-8. 2013
  5. pmc TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
    Celia Oreja-Guevara
    Department of Neurology, Neuroimmunology and Multiple Sclerosis Unit, University Hospital La Paz, Madrid, Spain
    BMC Neurol 12:95. 2012
  6. ncbi request reprint [Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids]
    Celia Oreja-Guevara
    Unidad de Esclerosis Multiple, Servicio de Neurologia, Hospital Clinico San Carlos, IdISSC, Madrid, Espana
    Rev Neurol 55:421-30. 2012
  7. pmc Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study
    Celia Oreja-Guevara
    Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, IdiPAZ Health Research Institute, University Hospital La Paz, Madrid, Spain
    PLoS ONE 7:e33907. 2012
  8. doi request reprint Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
    Celia Oreja-Guevara
    Department of Neurology, Neuroimmunology and Multiple Sclerosis Unit, Health Research Institute IdiPAZ, University Hospital La Paz Autónoma University of Madrid, Madrid, Spain
    Expert Rev Neurother 12:3-8. 2012
  9. ncbi request reprint [Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid
    Neurologia 24:435-8. 2009
  10. ncbi request reprint Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases
    A Garcia-Merino
    Servicio de Neurología Unidad de Neuroinmunología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Espana
    Neurologia 28:375-8. 2013

Collaborators

Detail Information

Publications10

  1. ncbi request reprint [Clinical pathways for the care of multiple sclerosis patients]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid, Espana
    Neurologia 25:156-62. 2010
    ....
  2. ncbi request reprint [Optic neuritis, multiple sclerosis-related or not: structural and functional study]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid, Espana
    Neurologia 25:78-82. 2010
    ....
  3. ncbi request reprint [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]
    J J Merino
    Instituto de Investigacion Sanitaria IdiPaz Hospital Universitario de La Paz HULP, Madrid, Espana
    Rev Neurol 52:101-11. 2011
    ..These trials have shown that their treatments are beneficial and complementary to treat complications of HIV/AIDS...
  4. doi request reprint Spasticity in multiple sclerosis: results of a patient survey
    C Oreja-Guevara
    Multiple Sclerosis Unit, Department of Neurology, IdISSC, University Hospital San Carlos, Madrid, Spain
    Int J Neurosci 123:400-8. 2013
    ..In appropriate patients, antispastic treatment, including pharmacotherapy and physiotherapy/rehabilitation, may provide such benefits...
  5. pmc TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
    Celia Oreja-Guevara
    Department of Neurology, Neuroimmunology and Multiple Sclerosis Unit, University Hospital La Paz, Madrid, Spain
    BMC Neurol 12:95. 2012
    ....
  6. ncbi request reprint [Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids]
    Celia Oreja-Guevara
    Unidad de Esclerosis Multiple, Servicio de Neurologia, Hospital Clinico San Carlos, IdISSC, Madrid, Espana
    Rev Neurol 55:421-30. 2012
    ..No tolerance, abuse or addictive issues have been found. New studies will be needed to find out potential new cannabinoid-related therapies...
  7. pmc Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study
    Celia Oreja-Guevara
    Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, IdiPAZ Health Research Institute, University Hospital La Paz, Madrid, Spain
    PLoS ONE 7:e33907. 2012
    ..This study aimed to evaluate RNFL thickness in patients at presentation with clinically isolated syndromes (CIS) suggestive of MS...
  8. doi request reprint Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
    Celia Oreja-Guevara
    Department of Neurology, Neuroimmunology and Multiple Sclerosis Unit, Health Research Institute IdiPAZ, University Hospital La Paz Autónoma University of Madrid, Madrid, Spain
    Expert Rev Neurother 12:3-8. 2012
    ..These are highly encouraging findings that provide some much needed optimism for the treatment of this disabling and often painful symptom of MS...
  9. ncbi request reprint [Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis]
    C Oreja-Guevara
    Servicio de Neurologia, Unidad de Neuroinmunologia Clínica y Esclerosis Múltiple, Hospital Universitario La Paz, Madrid
    Neurologia 24:435-8. 2009
    ..The objective of this study is to assess if glatiramer acetate (GA) is useful or not in patients who have discontinued interferon beta due to a suboptimal response or adverse events...
  10. ncbi request reprint Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases
    A Garcia-Merino
    Servicio de Neurología Unidad de Neuroinmunología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Espana
    Neurologia 28:375-8. 2013
    ....